Go Pro

Bank of Nova Scotia Buys Shares of 214,801 Synopsys, Inc. $SNPS

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Bank of Nova Scotia purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 214,801 shares of the semiconductor company's stock, valued at approximately $95,816,000. Bank of Nova Scotia owned about 0.11% of Synopsys as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Synopsys during the 2nd quarter worth about $747,400,000. Norges Bank bought a new stake in shares of Synopsys in the 4th quarter valued at about $730,197,000. SBI Okasan Asset Management Co.Ltd. acquired a new stake in Synopsys in the 4th quarter valued at about $1,699,000. Czech National Bank lifted its stake in Synopsys by 4.6% in the 2nd quarter. Czech National Bank now owns 54,526 shares of the semiconductor company's stock valued at $24,322,000 after purchasing an additional 2,421 shares during the last quarter. Finally, Atreides Management LP bought a new position in Synopsys during the first quarter worth about $54,288,000. 85.47% of the stock is owned by institutional investors.

Synopsys Price Performance

Synopsys stock opened at $397.87 on Friday. The company has a market capitalization of $76.18 billion, a price-to-earnings ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The stock's 50 day moving average is $419.73 and its 200-day moving average is $440.22.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. During the same period last year, the firm posted $3.67 EPS. The firm's revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity at Synopsys

In other news, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

SNPS has been the topic of a number of recent analyst reports. Robert W. Baird set a $558.00 price target on Synopsys in a research report on Thursday, May 28th. Zacks Research raised Synopsys from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, June 30th. KeyCorp reiterated an "overweight" rating on shares of Synopsys in a research note on Wednesday. Needham & Company LLC reissued a "buy" rating and set a $580.00 target price on shares of Synopsys in a report on Thursday, May 28th. Finally, Piper Sandler raised shares of Synopsys from a "neutral" rating to an "overweight" rating and lifted their price objective for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Synopsys has an average rating of "Moderate Buy" and a consensus target price of $563.59.

Check Out Our Latest Report on SNPS

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines